Trials / No Longer Available
No Longer AvailableNCT03005262
MLN8237 for a Subject With Adenocarcinoma of the Prostate
Expanded Access To MLN8237, For An Individual Patient With Adenocarcinoma Of The Prostate (CTMS# 16-0122)
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- Male
- Age
- 18 Years – 100 Years
- Healthy volunteers
- —
Summary
To allow a patient continued access to MLN8237
Detailed description
Expanded access to MLN8237 for an individual patient with adenocarcinoma of the prostate
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MLN8237 |
Timeline
- First posted
- 2016-12-29
- Last updated
- 2018-04-04
Source: ClinicalTrials.gov record NCT03005262. Inclusion in this directory is not an endorsement.